Cargando…
Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391632/ https://www.ncbi.nlm.nih.gov/pubmed/32728048 http://dx.doi.org/10.1038/s41392-020-00247-y |
| _version_ | 1783564677113970688 |
|---|---|
| author | Shao, Ting Chen, Tianzhi Chen, Yuning Liu, Xiaoyue Chen, Yi-Li Wang, Qi Zhu, Tong Guo, Maojun Li, Hui Ju, Dianwen Wang, Chunhe |
| author_facet | Shao, Ting Chen, Tianzhi Chen, Yuning Liu, Xiaoyue Chen, Yi-Li Wang, Qi Zhu, Tong Guo, Maojun Li, Hui Ju, Dianwen Wang, Chunhe |
| author_sort | Shao, Ting |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7391632 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73916322020-08-12 Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index Shao, Ting Chen, Tianzhi Chen, Yuning Liu, Xiaoyue Chen, Yi-Li Wang, Qi Zhu, Tong Guo, Maojun Li, Hui Ju, Dianwen Wang, Chunhe Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-07-29 /pmc/articles/PMC7391632/ /pubmed/32728048 http://dx.doi.org/10.1038/s41392-020-00247-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Shao, Ting Chen, Tianzhi Chen, Yuning Liu, Xiaoyue Chen, Yi-Li Wang, Qi Zhu, Tong Guo, Maojun Li, Hui Ju, Dianwen Wang, Chunhe Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index |
| title | Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index |
| title_full | Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index |
| title_fullStr | Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index |
| title_full_unstemmed | Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index |
| title_short | Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index |
| title_sort | construction of paclitaxel-based antibody–drug conjugates with a pegylated linker to achieve superior therapeutic index |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391632/ https://www.ncbi.nlm.nih.gov/pubmed/32728048 http://dx.doi.org/10.1038/s41392-020-00247-y |
| work_keys_str_mv | AT shaoting constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex AT chentianzhi constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex AT chenyuning constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex AT liuxiaoyue constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex AT chenyili constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex AT wangqi constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex AT zhutong constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex AT guomaojun constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex AT lihui constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex AT judianwen constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex AT wangchunhe constructionofpaclitaxelbasedantibodydrugconjugateswithapegylatedlinkertoachievesuperiortherapeuticindex |